Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

New Consumer Guide for Patients
The Agency for Healthcare Research and Quality, a division of the U.S. government recently published a consumer guide titled "Osteoporosis Treatments That Help Prevent Broken Bones: A Guide for Women After Menopause." For more information about this guide, please visit:
Learn More

Update on FDA Safety Review of Bisphosphonates
The FDA has issued a finalized safety review on bisphosphonates, like Risedronate (Actonel), and found no link between these medications and atrial fibrillation - an abnormal heart rhythm commonly known as "afib". Bisphosphonates are a type of medicine commonly used to treat patients with osteoporosis. For more information please visit:
Learn More

Date Published Title Drug Source
2008-07-03 New Consumer Guide for Patients Risedronic Acid MediGuard CRT
2008-11-14 Update on FDA Safety Review of Bisphosphonates Risedronic Acid FDA
2008-08-14 Weight gain associated with use of antipsychotics Risperidone MediGuard CRT
2009-01-15 Newer Antipsychotics Linked to Heart Risks Risperidone MediGuard CRT
2009-06-08 Antipsychotics Linked With Sudden Cardiac Death Risperidone MediGuard CRT
2009-09-30 Recall of Single Lot of Dr. Reddy's Risperidone (plain) 25 mg Tablets Risperidone Manufacturer
2009-10-29 Newer Antipsychotics Associated with Significant Weight Gain With Short-Term Use in Children and Adolescents Risperidone MediGuard CRT
2010-04-20 Risperidone: Dr. Reddy's Recalls Several Lots Risperidone FDA
2011-06-14 FDA Issues Warning About Medication Errors Due to Name Confusion Between Risperidone (Risperdal) and Ropinirole (Requip) Risperidone FDA
2011-06-18 Ortho-McNeil Voluntarily Recalls Two Lots: Risperdal (Risperidone) 3mg and Risperidone 2mg Risperidone Manufacturer
2011-08-16 Teva Pharmaceuticals Recalls Several Lots of Risperidone 0.25 mg, 0.5 mg, 1 mg, 2 mg and 3 mg Tablets Risperidone FDA
2008-09-12 New Safety Information: Rituxan (Rituximab) and Progressive Multifocal Leukoencephalopathy (PML) Rituximab Manufacturer
2009-10-26 Update on Risk of Progressive Multifocal Leukoencephalopathy (PML) with Use of Rituxan Rituximab FDA
2013-09-30 New Boxed Warning for Anti-Cancer Drugs Arzerra (Ofatumumab) and Rituxan (Rituximab) Rituximab FDA
2010-01-15 Voluntary Recall of Certain Lots of McNeil Over-the-Counter Products Rolaids Multi-Symptom Manufacturer
2011-01-18 McNeil Consumer Healthcare Initiates Voluntary Recall Of Certain Lots of Rolaids Multi-Symptom Rolaids Multi-Symptom Manufacturer
2012-01-26 FDA Makes Changes to Risk Evaluation and Mitigation Strategies (REMS) Program for Nplate (Romiplostim) and Promacta (Eltrombopag) Romiplostim FDA
2011-12-06 Corepharma LLC Recalls Several Lots of Ropinirole Hydrochloride Tablets, 0.25, 0.5, 1, 2 mg Ropinirole FDA
2012-03-27 Golden State Medical Supply Inc. Recalls Several Lots of Ropinirole 0.25 mg, 0.5 mg, 1 mg and 2 mg tablets Ropinirole FDA
2007-08-14 Some Diabetes Drugs to Strengthen Warning on Heart Failure Risk Rosiglitazone FDA
Back to Consumer Med Safety